113 related articles for article (PubMed ID: 9443789)
1. Induction of human osteoclast-like cells by treatment of blood monocytes with anti-fusion regulatory protein-1/CD98 monoclonal antibodies.
Higuchi S; Tabata N; Tajima M; Ito M; Tsurudome M; Sudo A; Uchida A; Ito Y
J Bone Miner Res; 1998 Jan; 13(1):44-9. PubMed ID: 9443789
[TBL] [Abstract][Full Text] [Related]
2. Suppression of FRP-1/CD98-mediated multinucleated giant cell and osteoclast formation by an anti-FRP-1/CD98 mAb, HBJ 127, that inhibits c-src expression.
Tajima M; Higuchi S; Higuchi Y; Miyamoto N; Uchida A; Ito M; Nishio M; Komada H; Kawano M; Kusagawa S; Tsurudome M; Ito Y
Cell Immunol; 1999 May; 193(2):162-9. PubMed ID: 10222058
[TBL] [Abstract][Full Text] [Related]
3. Gene expression during osteoclast-like cell formation induced by antifusion regulatory protein-1/CD98/4F2 monoclonal antibodies (MAbs): c-src is selectively induced by anti-FRP-1 MAb.
Higuchi Y; Ito M; Tajima M; Higuchi S; Miyamoto N; Nishio M; Kawano M; Kusagawa S; Tsurudome M; Sudo A; Katou K; Uchida A; Ito Y
Bone; 1999 Jul; 25(1):17-24. PubMed ID: 10423017
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules.
Ohgimoto S; Tabata N; Suga S; Nishio M; Ohta H; Tsurudome M; Komada H; Kawano M; Watanabe N; Ito Y
J Immunol; 1995 Oct; 155(7):3585-92. PubMed ID: 7561057
[TBL] [Abstract][Full Text] [Related]
5. Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes.
Namba K; Nishio M; Mori K; Miyamoto N; Tsurudome M; Ito M; Kawano M; Uchida A; Ito Y
Cell Immunol; 2001 Nov; 213(2):104-13. PubMed ID: 11831872
[TBL] [Abstract][Full Text] [Related]
6. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
7. Regulation of human immunodeficiency virus gp160-mediated cell fusion by antibodies against fusion regulatory protein 1.
Ohgimoto S; Tabata N; Suga S; Tsurudome M; Kawano M; Nishio M; Okamoto K; Komada H; Watanabe N; Ito Y
J Gen Virol; 1996 Nov; 77 ( Pt 11)():2747-56. PubMed ID: 8922468
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between RANKL and FRP-1/CD98 Systems: RANKL-mediated osteoclastogenesis is suppressed by an inhibitory anti-CD98 heavy chain mAb and CD98-mediated osteoclastogenesis is suppressed by osteoclastogenesis inhibitory factor.
Mori K; Miyamoto N; Higuchi Y; Nanba K; Ito M; Tsurudome M; Nishio M; Kawano M; Uchida A; Ito Y
Cell Immunol; 2001 Feb; 207(2):118-26. PubMed ID: 11243701
[TBL] [Abstract][Full Text] [Related]
9. Identification of fusion regulatory protein (FRP)-1/4F2 related molecules: cytoskeletal proteins are associated with FRP-1 molecules that regulate multinucleated giant cell formation of monocytes and HIV-induced cell fusion.
Suga S; Tsurudome M; Ohgimoto S; Tabata N; Watanabe N; Nishio M; Kawano M; Komada H; Ito Y
Cell Struct Funct; 1995 Dec; 20(6):473-83. PubMed ID: 8825068
[TBL] [Abstract][Full Text] [Related]
10. An anti-fusion regulatory protein-1 monoclonal antibody suppresses human parainfluenza virus type 2-induced cell fusion.
Okamoto K; Tsurudome M; Ohgimoto S; Kawano M; Nishio M; Komada H; Ito M; Sakakura Y; Ito Y
J Gen Virol; 1997 Jan; 78 ( Pt 1)():83-9. PubMed ID: 9010289
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of osteoclast-selective monoclonal antibodies that distinguish between multinucleated cells derived from different human tissues.
James IE; Walsh S; Dodds RA; Gowen M
J Histochem Cytochem; 1991 Jul; 39(7):905-14. PubMed ID: 1865107
[TBL] [Abstract][Full Text] [Related]
12. Function of fusion regulatory proteins (FRPs) in immune cells and virus-infected cells.
Tsurudome M; Ito Y
Crit Rev Immunol; 2000; 20(3):167-96. PubMed ID: 10968370
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of monoclonal antibodies directed against murine FRP-1/CD98/4F2 heavy chain: murine FRP-1 is an alloantigen and amino acid change at 129 (P<-->R) is related to the alloantigenicity.
Tsumura H; Kawano M; Tajima M; Kusaura T; Kozuka Y; Yoshimura S; Komada H; Tsurudome M; Nishio M; Kusagawa S; Shimura K; Ito Y
Immunol Cell Biol; 1999 Feb; 77(1):19-27. PubMed ID: 10101682
[TBL] [Abstract][Full Text] [Related]
14. Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay.
Husheem M; Nyman JK; Vääräniemi J; Vaananen HK; Hentunen TA
Calcif Tissue Int; 2005 Mar; 76(3):222-30. PubMed ID: 15692727
[TBL] [Abstract][Full Text] [Related]
15. Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells.
Miyamoto N; Higuchi Y; Tajima M; Ito M; Tsurudome M; Nishio M; Kawano M; Sudo A; Uchida A; Ito Y
J Orthop Res; 2000 Jul; 18(4):647-54. PubMed ID: 11052502
[TBL] [Abstract][Full Text] [Related]
16. Characterization of two types of osteoclasts from human peripheral blood monocytes.
Yuasa K; Mori K; Ishikawa H; Sudo A; Uchida A; Ito Y
Biochem Biophys Res Commun; 2007 May; 356(2):354-60. PubMed ID: 17368425
[TBL] [Abstract][Full Text] [Related]
17. The functional interaction between CD98 and CD147 in regulation of virus-induced cell fusion and osteoclast formation.
Mori K; Nishimura M; Tsurudome M; Ito M; Nishio M; Kawano M; Kozuka Y; Yamashita Y; Komada H; Uchida A; Ito Y
Med Microbiol Immunol; 2004 Nov; 193(4):155-62. PubMed ID: 12925876
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of avian osteoclast bone resorption by monoclonal antibody 121F: a mechanism involving the osteoclast free radical system.
Collin-Osdoby P; Li L; Rothe L; Anderson F; Kirsch D; Oursler MJ; Osdoby P
J Bone Miner Res; 1998 Jan; 13(1):67-78. PubMed ID: 9443792
[TBL] [Abstract][Full Text] [Related]
19. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures.
Ikegame M; Rakopoulos M; Martin TJ; Moseley JM; Findlay DM
J Bone Miner Res; 1996 Apr; 11(4):456-65. PubMed ID: 8992876
[TBL] [Abstract][Full Text] [Related]
20. Induction of c-Src in human blood monocytes by anti-CD98/FRP-1 mAb in an Sp1-dependent fashion.
Miyamoto N; Higuchi Y; Tsurudome M; Ito M; Nishio M; Kawano M; Sudo A; Kato K; Uchida A; Ito Y
Cell Immunol; 2000 Sep; 204(2):105-13. PubMed ID: 11069718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
